In conclusion, nutraceuticals represent a promising strategy for improving metabolic abnormalities, such as diabetes, thanks to their capacity to decrease inflammation by modulating NLRP3 inflammasome and its downstream pathways. The gene discussed is NLRP3; the disease is diabetes mellitus.